<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T17:39:46Z</responseDate><request verb="GetRecord" identifier="oai:ruor.uottawa.ca:10393/40737" metadataPrefix="oai_dc">https://ruor.uottawa.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:ruor.uottawa.ca:10393/40737</identifier><datestamp>2024-02-23T08:57:35Z</datestamp><setSpec>com_10393_242</setSpec><setSpec>col_10393_11105</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Risk Factors, Mechanisms and Therapeuthic for Right Heart Failure Associated with Pulmonary Hypertension</dc:title>
   <dc:creator>Zelt, Jason</dc:creator>
   <dc:contributor>Mielniczuk, Lisa Marie</dc:contributor>
   <dc:contributor>Beanlands, Rob</dc:contributor>
   <dc:subject>Right Heart Failure</dc:subject>
   <dc:subject>Pulmonary Hypertension</dc:subject>
   <dc:subject>Adenylate Kinase</dc:subject>
   <dc:subject>Metabolism</dc:subject>
   <dc:subject>Sympathetic Nervous System</dc:subject>
   <dc:subject>Positron Emission Tomography</dc:subject>
   <dc:description>Right ventricular function (RV) is one of the most important predictors of prognosis in&#xd;
many cardiovascular disease states. Despite the significance of RV function to survival, there are&#xd;
no therapies that directly nor selectively improve RV function. As well, the basis for RV failure&#xd;
is poorly understood. This is particularly relevant for patients with pulmonary arterial&#xd;
hypertension (PAH), where RV failure in the setting of pressure overload is the leading cause of&#xd;
death. PAH will be introduced in the 2nd chapter of this thesis by comparing and refining&#xd;
contemporary mortality risk assessment strategies. I will then explore 1) RV neurohormonal&#xd;
function and, 2) RV energetics, two molecular pathways thought to be involved in the&#xd;
pathogenesis and progression of maladaptive RV failure. I employed small animal molecular&#xd;
imaging using positron emission tomography (PET) to non-invasively investigate these&#xd;
pathways. The PET imaging techniques employed in this thesis have the unique potential for&#xd;
translation to human studies, to further explore disease mechanisms.</dc:description>
   <dc:date>2020-07-16T18:24:55Z</dc:date>
   <dc:date>2021-01-16T10:00:07Z</dc:date>
   <dc:date>2020-07-16</dc:date>
   <dc:type>Thesis</dc:type>
   <dc:identifier>http://hdl.handle.net/10393/40737</dc:identifier>
   <dc:identifier>http://dx.doi.org/10.20381/ruor-24965</dc:identifier>
   <dc:language>en</dc:language>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Université d&amp;apos;Ottawa / University of Ottawa</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>